Safety of propoxyphene in dialysis patients

Seminars in Dialysis

Volumn 15, Issue 5, 2002, Pages 375-

  Bailie, George R ^a   Johnson, Curtis A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROPROPOXYPHENE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CHRONIC KIDNEY FAILURE; FOLLOW UP; HUMAN; KIDNEY FUNCTION TEST; METHODOLOGY; PAIN; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SAFETY;

ANALGESICS, OPIOID; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; PAIN; PROPOXYPHENE; RENAL DIALYSIS; RISK ASSESSMENT; SAFETY;

EID: 18744416959     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2002.t01-1-00911.x     Document Type: Note

References (3)

1. Giacomini KM, Gibson TP, Levy G: Effect of hemodialysis on propoxyphene and norpropoxyphene concentrations in blood of anephric patients. Clin Pharmacol Ther 27:508-514, 1980
2. Gibson TP, Giacomini KM, Briggs WA, Whitman W, Levy G: Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient. Clin Pharmacol Ther 27:665-670, 198O
3. Heinrich WL, Agodoa LE, Barrett B, Bennett WM, Blantz RC, Buckalew VM, D'Agati VD, DeBroe ME, Duggin GG, Eknoyan G, Elseviers MM, Gomez A, Matzke GR, Porter GA, Sabatini S, Stoff JS, Striker GE, Winchester JF: Analgesics and the kidney: summary and recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation. Am J Kidney Dis 27:162-165, 1996